Ladies and gentlemen, thank you for standing by. And welcome to the Fourth Quarter 2020 Avient Corporation Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advice that today’s conference is being recorded. [Operator Instructions] I would like to hand the conference over to one of your speakers today, Mr. Joe Di Salvo, VP, Treasurer and Investor Relations. Sir, please go ahead.

Thank you, Michelle, and good morning. And welcome to our fourth quarter 2020 earnings call. Before beginning, we’d like to remind you that statements made during this webcast may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements will give current expectations or forecasts of future events and are not guarantees of future performance. They’re based on management’s expectation and involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statement. Please refer to investor presentation for the webcast posted on the Avient website for a number of factors that could cause actual results to differ. During today’s discussion, the company will use both GAAP and non-GAAP financial measures. Please refer to the presentation posted on the Avient website, where the company describes the non-GAAP financial measures and provides a reconciliation for historical non-GAAP financial measures to the most directly comparable GAAP financial measures. In addition, unless otherwise stated comparisons to prior year will be pro forma for the Clariant Masterbatch acquisition, as if the business had been together during all periods referenced. Joining me today is our Chairman, President and Chief Executive Officer, Bob Patterson; and Senior Vice President and Chief Financial Officer, Jamie Beggs. Now I will turn the call over to Bob.

Well, thanks, Joe, and good morning, everyone. I’d like to start this morning in the same way we have the last few quarters with an acknowledgement and words of support for those who have been impacted by the COVID pandemic. The rollout of a vaccine brings new hope, yet this pandemic is not over and we remain mindful of the many ways it is impacting people around the world. Our heartfelt appreciation goes out to the countless frontline workers and first responders, as they continue to play such an important role in the response. Looking back on 2020, it was certainly a year like no other and I’m extremely pleased with how we finished delivering record fourth quarter results. The demand we reported in December surpassed our expectations as every segment and region grew over the prior year. Fourth quarter sales increased 8% to just shy of $1 billion, which is a record for Avient. Demand for applications and consumer and healthcare applications strengthened considerably. From a bottomline perspective, this growth coupled with Clariant synergy capture, increased our EPS to $0.52 on an adjusted basis. That’s better than we expected back in December and 73% higher than the prior year. As I said, each of our three segments delivered strong revenue and operating income growth for the quarter, with SEM leading the way. EM had its highest ever quarterly operating income expanding that measure by 58%, driven by demand for our composite technologies and in the outdoor high performance space. Color, Additives and Inks also achieved record operating income growing 45%. The Color segments certainly benefited from early synergy capture and the reopening of the economy. But also contributing was increased demand for consumer applications, as well as gains in healthcare and sustainable solutions for food and beverage packaging. And…

Thank you, Bob. As 2021 is already in full swing, we would like to provide some context and outlook for the upcoming year. We clearly finished 2020 with impressive results and we are continuing to see robust demand in the first quarter of 2021. Yet, like everyone, we remain mindful that the Coronavirus pandemic continues and with that comes potential volatility as we make our way through the year. Things that we can’t control include the integration with Clariant. I continue to be amazed that the energy and excitement that is being generated from the combined organizations and couldn’t be more proud of how we’ve come together as a team. As for integration in the coming year, we expect to realize $35 million of synergies in 2021, which is an incremental $30 million over 2020. The synergies will primarily be driven by harmonization of raw material pricing and integration of administrative functions. For the first quarter, we expect total company sales to increase approximately 10%. Specifically, we expect the healthcare and consumer end markets to lead the way with strong double-digit growth. Healthcare sales will be driven by new business gains and applications such as glucose monitoring devices, antigen test kits and specialized medical tubing. We also see recovering demand for applications used in elective procedures. Consumer sales will benefit from continued underlying demand for composite technologies used in outdoor high performance applications such as snowmobiles and ATVs. Packaging is also expected to provide mid-to-high single-digit growth, led by demand for sustainable solutions for food and beverage packaging. An example includes performance additives that facilitate the use of recycled PET. Lastly, certain end markets such as transportation should also provide growth, benefiting from the economic recovery as automakers ramp up production. The bottomline impact of all of this is that…

Thanks, Jamie. Before we take questions, I wanted to share a couple other slides that I’m sure most if not all of you have seen from our previous investor presentations and I’ll start with this. Avient is a new company. How, where and why we win is important for our investors to understand. Because we have a unique position and play a critical role in product development for our customers. We provide over 21,000 customers formulated solutions, not commodities. We do this fast, we do this often and we do it all over the world with over 100 production and distribution facilities. We are where our customers need us. When we win we create value for you and all our stakeholders. We covered each of these levers at various points throughout today’s webcast. But in summary, here are the key reasons why we are creating value now and why we’re set up well to continue to do so far into the future. Our growth projections for 2021 reflect a strong start to the year and are appropriately conservative. While we are benefiting from a combination of new business gains and early signs of economic recovery, the full year impact of when and how vaccine rollout will take place is still to be determined. Regardless, we expect improving mix from continued strong demand for our sustainable solutions, healthcare and composites, as Jamie said, and this along with synergy capture will drive 24% adjusted EPS growth. This translates to EBITDA of $510 million, which will be by far the highest in the company’s history and with significant upside in years to come for all the reasons we’ve covered today. In doing this we will reduce our net leverage to 2.1 times and have the balance sheet flexibility to invest in future innovation…

[Operator Instructions] Our first question comes from the line of Mike Sison with Wells Fargo. Your line is open. Please go ahead.

Hey. Good morning. Congrats on a strong 2020. Bob can you maybe walk through some of the sales synergy potential you see with Clariant as we head into ‘21?

Yeah. I mean, I think, in 2021, there is a really important focus that we have on basically business as usual when I think about combining the two legacy PolyOne and Clariant organizations. There’s obviously a ton of work to do, Mike, with respect to responding to -- the response and recovery efforts of COVID. Those are the highest priorities. So I think in 2021, it’s about identifying opportunities for future years and the areas of focus will be on sustainable solutions, healthcare, most likely packaging, as you would imagine. And the work that’s taken place so far is really looking at where we’ve got overlapping customer opportunities, as well as overlapping streams of R&D and customer support activities. So those are the areas, but I really see the longer term benefit from revenue synergies coming in post-’21.

Got it. And then for engineering materials, composites has been -- has gained a lot of momentum over the last couple of years. Can you maybe give us an update, how big that business is now? What type of growth do you see in composites in ‘21?

Yeah. Look, it’s just a little bit over. It’s about $200 million of revenue in total. If you look at the bridge schedule that Jamie walked you through, it will give you the composite assumptions for this year. Look, there is an assumption in here that this year that maybe some of what we saw in the fourth quarter doesn’t repeat. Maybe that’s conservative. We’ll see how this year plays out. But I think if you put those two together, Mike, that will help you get a sense for composite numbers for this year.

Great. Thank you.

Yeah.

Thank you. And our next question comes from the line of Bob Koort with Goldman Sachs. Your line is open. Please go ahead.

Good morning. Thanks very much. Bon, on the Color business, obviously, some very strong [inaudible] and integration. How do you think about maybe a mid or longer term target on margin structure that after you’ve harvested all those synergies? What might you think is a run rate a few years out?

Yeah. I mean, obviously, we’re already off to a really good start there. And the legacy PolyOne Color business as you know had EBITDA margins in excess of 20%. And I view that as a really good long-term target for what this segment can ultimately do together and we’ve talked a little bit about some differences between the two portfolios of legacy Clariant versus legacy PolyOne, but I don’t see why we can’t get back to that level of performance.

Then I know you guys have worked on ESG type stuff for quite a long time before it was fashionable. I am wondering, I don’t know, maybe Joe is the right guy to answer this. But how have you seen imbalance from that investment theme and what are you guys doing to cultivate that since it sure seems like a value enhancement option for a lot of companies out there as you say?

Hey, Bob. Yeah. This is Joe. It’s been something that has been part of our strategy, quarter of our strategy, right? It’s not something we just started doing, because it became in vogue and so it is part of our growth strategy. We do get a lot of discussions or questions from -- inbound questions from investment -- investors on this topic. And if you look at our most recent sustainability report, we’ve really beefed that it up and added goals -- long--term goals and targets to help address some of the metrics that are out there from the regulatory bodies in this area. And so it’s really starting to gain some traction, if you look at some of the conferences will be out here. In the next couple of months, we’ll be targeting ESG conferences with some of the sell side to help continue to promote this. But it’s really starting to gain traction momentum and it’s something that we’ve been doing for many years. It’s not something that’s new to us. So thanks for pointing that out.

Got you. Okay. Thanks, guys.

Thank you.

Thank you. And our next question comes from the line of Frank Mitsch with Fermium Research. Your line is open. Please go ahead.

Good morning and nice end to the year. Bob, I want to follow up on the comment you made -- you use the term you’re -- in your guide, I thought you use the term with respect to guidance here we talked about appropriately conservative. Now it turns out that the $0.48 guidance you issued for the fourth quarter in the middle of December turned out to be appropriately conservative What went right to be able to post that the in the fourth quarter?

Yeah. So the comment that I was making conservative about really was related to 2021. When I was saying, I think, we’re being appropriately conservative and I’m happy to come back to that. But with respect to specifically Q4, really it was almost entirely and we had some level of revenue beat, which was generally just demand across all regions and all businesses, very strong finish to the year and a little bit better margins in the Color segment.

Got you. And I don’t think I’ve ever been teed up better by a CEO to ask the follow up question. So, yeah, let’s come back to the appropriately conservative $2.40 for ‘21.

Well, one thing that we have in this estimate is, I think, I really conservative sort of sec view on the second half of the year, specifically the fourth quarter. Obviously, it’s way too early to call or project what is going to happen. But the reality is the fourth quarter of 2020 was the strongest we’ve ever had. Typically we’ve got seasonality in this business and Q4 is typically weaker than Q3 that didn’t occur in 2020. And so as we’ve modeled and created the $2.40, I think, we’ve been conservative with respect to what we think Q4 of this year will look like. Secondly, I think, we’re also being conservative with respect to margins. I just think we’re going to have better margins than kind of what rolls up and builds into this number. But what we’ll see as the year progresses. We certainly had a great track record with margin expansion in the second half of 2020.

Very helpful. And just to confirm, you’re currently modeling in fourth quarter to be seasonally down as it historically is relative to the third quarter, correct?

That is correct.

Thank you, sir.

Yeah.

Thank you. And our next question comes from a line of P.J. Juvekar with Citi. Your line is open. Please go ahead. P.J., your line might be on mute. All right, we’ll move to the next question. Our next question comes from the line of Vincent Andrews with Morgan Stanley. Your line is open. Please go ahead.

Hi. Thank you for taking our question. This is Angel Castillo on for Vincent. Just a quick follow up, I guess, on the cash deployment aspect. I think in the past you have talked about you interested in composites and continuing to grow these high growth specialty businesses. But maybe there was a little bit of, I guess, delay or I guess impact from COVID-19 and the ability to travel. As you get -- look at 2021 and where we are today, how are you seeing, one, your pipeline evolve, and two, are some of these potential opportunities continuing to move forward and -- despite the delays?

Yeah. I think, the -- I mean, the dialogue is continuing with some of the opportunities that we started those discussions with last year. Some feel a little bit like they’re in a holding pattern, because of what you just said that we can’t travel and really just feel like that’s an unnecessary thing to do. Seller seem to be okay with that. We’re okay with that. There’s a couple others, though, that are businesses that we have already had a relationship with and know well that could be further along. So it is kind of a spectrum of things. I think that where the real challenge comes in, of course, is just if you haven’t been to the plants, if you haven’t met the team before, really difficult to move something forward until you can do so in person.

That’s very helpful. Thank you. And then just wanted to ask about the free cash flow guidance of $250 million for 2021, obviously, another strong year and some -- as you mentioned, some use of working capital. As we think about the role of Clariant, I think, Clariant just year-over-year, if we assume kind of the first half of 2020 wasn’t included was a $30 million to $35 million tailwind for next year? And then also just thinking about working capital improvement, I think, in the past you’d said that just proving or getting Clariant where legacy PolyOne is, it’s kind of like a 2 points to 3 points of improvement from our working capital perspective. So just was wondering if that’s included in the guidance with that potential upside just from what you’ve kind of laid out?

I mean, you’re correct on the headline difference between their legacy working capital as a percentage of sales and our own. We do not have the Clariant working capital number getting all the way to where legacy PolyOne is in 2021. But we do have improvement on a percentage of sales basis in there. So could it be upside if we do better, certainly. But for right now, we’ve just got a modest improvement.

Understood. Thank you.

Thank you. And our next question comes from P.J. Juvekar with Citi. Your line is open. Please go ahead.

Hey. Good morning. Sorry about that. Can you hear me?

Yes. We can.

Great. Thanks, Bob. When you gave guidance of 8% organic growth next year, I mean, next year, I’m in 2021. Can you break that down between price and volume? How much pricing power do you have with oil prices and raw materials in general going up? Do you expect any further pricing? And then sort of related to that question on organic growth, how much of your sales would you say are from products that were introduced in the last three years? Is that a metrics that you track? Thank you.

I’ll take the last one first and that is, we do track a vitality index. However, we track percentage of revenue from products introduced in the last five years. So I don’t know a three-year number. But I can tell you in the last five years, our expectation is percentage of sales should be right around 36% or 37%. So we’ve always considered anything above 35% to be world class. So I think in 2021 we will be right in the -- right down a fair way of what we -- where we’d want to be in that regard. With respect to the 8% sales growth, there is some FX contribution in there. You can see that in the bridge schedule that we’ve got in the deck. You look, but beyond that, we effectively view that growth is principally underlying unit demand. And the reason why we come back to that is because, I know there’s been a lot of questions and thoughts on inflation and what’s taking place. Right now we have two areas in particular, polyethylene and polypropylene. They get a lot of focus and attention. It’s a very small percentage of what we buy. And we could probably give it even more robust answer on raw materials, if somebody wants it. But I just tell you right now, we’re not -- we don’t have something in our plan for a major inflationary price increase, because we’re not seeing that yet. But we would handle that appropriately if we did. So, I guess, the way to think about that 8% is that’s real underlying demand growth excluding the FX delta I just described.

Great. And just a quick question on your Masterbatch’s deal, given how well it worked for you and your execution was quite good. Why wouldn’t you look at another deal similar to that, given low rates and take advantage of that? And can you talk about the pipeline and what your thinking is there? Thank you.

Yeah. I mean, look, we would love to do another deal like this, right? And I’d say, what the Clariant deal was a number of years in the making, from the first time we ever started talking about it to when we earnestly started talking about it to when we finally got it done in July of 2020. So, unfortunately, these things do take time. I’d say, there’s a number of things that we are looking at, that we are excited about. What I love is that look, when you look at the cash flow we generated this last year, what we’re projecting for 2021. We’re going to get something done if and when we can, and we think it’s a good fit. It’s just a matter of having all that lineup so that we can. So that’s the plan.

Thank you so much.

Thank you. And our next question comes from the line of Mike Harrison with Seaport Global Research Securities.

Hey. Good morning. Can you hear me okay?

Hi, Mike. We can.

Great. I wanted to kind of come back to this raw material question, maybe can you take a step back and discuss some of the changes that have occurred in the raw material slate now that your Color business has doubled in size. You mentioned PE and PP are smaller components that -- than people might think, presumably pigments have increased in terms of your spend. So talk about that and maybe what your outlook is for inflation in some of those pigment base raw materials.

Hi, Mike. This is Jamie. That’s a great observation. So about half of our raws now are non-hydrocarbon based primarily with the CIA portion of our business, which is pigments, PiO2 and performance additive. They’ve been very stable through 2020 and our outlook is for 2021. For perspective, going back to polyethylene and polypropylene that Bob mentioned earlier, those only represent 15% of our raw materials. And even so it takes a little bit more effort to dig into it a little bit more because of the market indices don’t really represent exactly what we purchased for our businesses. In particular, we buy plastic extrusion formulations and we also purchase those polymers and recycled content as well. So we don’t see the magnitude of inflation that you would normally see just by looking at the indices. And I think lastly, it’s -- a lot of the headlines today is in the North America region. And in fact, if we talk about polyethylene and polypropylene, Europe was down in Q4. And so if you did a walk of what happened last quarter, we actually saw raw material benefit. And while we do see some of the market indices moving up for 2021, like Bob said, we don’t think the magnitude is that large and where there is some pockets where that might be the case, we definitely have the ability to raise price to be able to push that through.

All right. That’s very helpful. Thanks. And then, Bob, maybe can you talk a little bit about the cyclical businesses? It seems like you’re expecting a recovery to continue into 2021. Maybe comment on what you’re seeing in terms of monthly trends in some of those businesses and some thoughts on where customer inventory levels are and any potential for restocking cycle in 2021?

Sure. Just as a reminder, you mentioned cyclical, so I’ll just throw out, maybe transportation, which is about 8% of sales, building and construction is even less. Those things of all seem to have trended positively in the last few months, as you know. There is some sort of headline, let’s say, concerns about the ability to continue to do so, because of chip shortages and things like that that’s impacting the automotive industry. But anyway, I think there’s continued improvement in these cyclical spaces and we’re seeing that right now. Well, the second part of your question, I think, was related to customer inventories. And I tell you, it’s a really challenging time right now, because a lot of raw materials are actually in short supply. And I think customers are feeling that. We certainly are. And I think that -- I don’t think anybody is stockpiling stuff right now or feeling like they’ve got enough to be content. In some cases, people are trying to get whatever they can for those things that are in short supply, because demand continues to be very strong. So I don’t think we’re sitting on a lot of inventory right now. I don’t think our customers are either, and hopefully, that’s a good thing for demand here for the first part of the year.

All right. Thanks very much.

Yeah.

Thank you. And our next question comes from the line of Ben Kallo with Baird. Your line is open. Please go ahead.

Hey, guys. Finally…

Hi, Ben.

So, hey, Bob, you gave a point guidance for 2021. I don’t think you’ve ever done a new on the stock, maybe just like eight years or nine years. But I don’t think you done, correct, [ph] you talk about of visibility a little bit. And then two, like, if we go back to your last Analyst Day and then the one before that, it started out with OpEx guidance and that was, you talked about that before is, is a driver of the stock or the company and what you’re focused on. And then the last Analyst Day you talked more about ROIC and so could you both talk about that visibility into your guide? And then what metrics you are looking for as you go forward that we should be looking for, there was like silver and platinum and gold or for whatever it was?

Great. There’s a lot of stuff in there, Ben.

I know.

Let me see how I can. I’ll take these here in the order I can remember them. So well starting point was a $2.40. I mean, look, some people prefer to give a range. Others may prefer to just give a point estimate that they kind of view as a best estimate. Candidly, either one of those is based on assumptions and certain scenarios as you put into the forecast, I’ve tried to convey one or two of those scenarios already in the sense of kind of how we look at Q4 for this year, maybe margins and looking at those things kind of conservatively. So -- and philosophically other people kind of just have their feelings about whether or not a range is helpful, because sometimes it says you exactly know the lower end and the higher end and that’s not always true either. So, hey, look, this is our best estimate. I think it’s a really good way to start the year and I think a great point estimate for us to think about for the year. With respect to going back to some of those previous Investor Days, I think, look, ROIC is always going to be important, right? That’s just a measure of how well we’re doing against our investment dollars. And I think you were harkening back to an Analyst Day or even way before that, right, which was all about margins. And there’s a really good slide from that, that we really should resurrect, because I think that margin growth is going to be an important part of our story going forward as it was then. I tried to make that comment in the call today, which is that for those of you who have followed us for a long time and as you have, you remember that, and I think, that’s going to be important part of the growth story. So we didn’t have a slide on that with respect to margin projections. I think as this year goes on and we see how this plays out for this year, though, that’s worth revisiting. And I know Bob asked a similar question about where Color can get to. So anyway, I feel really good about our trajectory. I think we’re on a really good path with respect to those things and if year goes on…

Maybe.

…I think we can put more data around it.

Maybe I’ll jump into and thanks. I know you’re coming to our sustainability conference. But from a broader perspective now, do you guys envision doing a kind of Analyst Day or some revisit to what you’re doing and when would you think that would happen? Sorry, Joe.

Did you say sorry, Joe? Joe is…

Yeah. He can go out work. Yeah.

Yeah.

Yeah. Let me clear my next six months.

Yeah. I think we’ll give that some consideration, Ben, and we’ll report back to you.

All right. Thanks, guys.

Certainly.

Thank you. And our next question comes from a line of Colin Rusch with Oppenheimer. Your line is open. Please go ahead.

Thanks so much. Bob, can you speak to any discussions that you’re having around while waiting the material replacements outside of outdoor performance at this point, particularly as it gets into the auto sector and some of these other areas where you guys have some meaningful opportunities for lightweighting?

Yeah. I mean, look, there is still -- I mean, right at the top of the list for your transportation applications. I mean, I mentioned in response to an earlier question that that’s not as bigger part of our portfolio as it once was, but look at still 8% to 9% of our sales in a matter. So I’d say applications and transportation are still really important in that regard. And as you know, look, we do lots and lots of small things. So we wouldn’t be pointing to something that’s massive in scale in terms of application examples, but the ones that we are doing in those space are very much focused on lightweighting and they matter. What was I thought interesting about this last year was that, in some respects, it kind of felt like maybe innovation got put into the parking lot. But in other respects, it seemed like the ability to communicate more frequently with customers by WebEx, maybe actually put some things back on the table that weren’t before. So I was actually really encouraged sort of net-net on the year with respect to how much customers are still thinking about lightweighting. They are thinking about sustainable solutions. It can be lightweighting in packaging is a big deal. I think you mentioned outdoor performance and we obviously talked about that a lot. But lightweighting for packaging is right at the top too.

Okay. That’s super helpful. And I think kind of leading into my next question, we’re seeing an increasing number of companies make commitments around reaching net zero by 2040. And obviously, with the robust ESG practice that you guys have allows you a certain amount of transparency, not just around environmental issues, but your entire business, where are you seeing in terms of customer engagement on trying to work towards some of those net zero goals with you guys as a supplier? It seems like some of that purchasing power is going to start dictating operational terms for different companies. Just curious, how mature that is and kind of where you’re at with it, that sort of this year?

Yeah. I mean, look, I think, it’s mature. I think that there’s a lot of customer energy, excitement and support for discussion around sustainability initiatives, I mean, like never before. I mean, it used to be something that was kind of an interesting side conversation, but didn’t get a lot of traction unless a customer thought it was somehow going to be cheaper. That’s just not the case anymore. And I’ll tell you, it -- we’re having some really robust conversations with customers and you talked about sustainability and things we can help them do and help ourselves. It’s front and center with respect to new product development.

Thanks so much, guys.

Sure.

Thank you. And our next question comes from the line of Laurence Alexander with Jefferies. Your line is open. Please go ahead.

Hi, guys. And it’s Laurence. How are you?

Hi. Good.

So just getting back to the revenue synergies? I know, you mentioned that the first priority is identifying them. I was just wondering how long the runway is from there. I mean, after they’re identified, is there a long sales cycle, because it takes like a year or two to kind of really make traction with generating additional revenue from cross-selling?

Well, look, there’s already some that are identified. I think it’s a spectrum of both identification and then sales cycle timing. So certain things, look, we’re just talking about bringing Clariant and legacy PolyOne together. So I’ll just focus on Color for the time being. Some of these things are food and beverage packaging related, some are healthcare, that can be long cycle stuff, right, particularly with respect to additives and I do think additives is a big area of opportunity. So some of that longer cycle. Some of it, I think, could be quick wins that we get as early as the end of this year by bringing the businesses together. I just want to continue to reiterate just how important it is to have business as usual for a period of time, as we bring customers together as we align our sales and commercial organizations. I think that message is really important. And then, lastly, as to maybe a follow on to the last question-and-answer session on sustainable solutions. I think those things actually would historically have a longer cycle time, but customers are going to make them happen faster. So those kinds of things could happen again as soon as the end of this year, beginning of next year.

All right. Thank you for the color there. And then just one other question, some of the other companies have mentioned that there’s some logistical issues recently just due to a pandemic, are just raising costs. I was wondering if you guys have seen something similar.

Logistical issues, I mean, if you mean with respect to like raw material shortages. That is certainly something we’ve seen in a variety of different places. It has caused some disruptions in a few of our businesses. But that’s it. Look, with respect to freight, freight costs are going up, things are getting tight. That makes things more challenging at times. But nothing else that’s on our radar screen unless I miss understood your question.

No. I was referring to actually freight and transportation costs. But you did answer it.

Okay.

Thank you.

Thanks, Laurence.

Thank you. And our next question comes from the line of Jaydeep Gandhi with Armfield Security [ph]. Your line is open. Please go ahead.

Thanks a lot.

Jaydeep, your line might be on mute.

Very good growth in the Clariant legacy business last year, 13%, despite. Hello, can you hear me?

Yes. We can hear you.

We can hear you.

We could hear you.

Jaydeep, your line might be on mute.

Hello. Hello.

Yeah. We can hear you? We can hear you.

Hi. Can you hear me?

Yes.

Hello? Hello? Yes. Hi. Yes. Yeah. I was just going to start with a Clariant legacy business where you saw 13% growth in EBITDA, if you can give us some color on organic growth and sort of what was driving this given the fact that you only had $5 million synergies last year? And then sort of more longer term question around this business is, if I sort of throw in your synergy target in there. Do you think fundamentally this business actually if you guys were running it and you throw all the sort of right growth elements to it, would be in your top tier in terms of margins? So that’s the first question. The second question is sort of around your healthcare business actually and maybe together of Avient and Clariant. Do you have any opportunity with regards to catheters and vials, especially in this vaccination drive as the world sort of scramble for glass vials? That’s my second question. And then, finally, I know you probably want to do this in a step by step manner, but when I look through your synergy targets for Clariant and you’ve upgraded a sourcing element, but do you think there is still quite a lot of scope for you to combine the production network between the two companies, now that it is one company really, and therefore, there is -- there could be more scope for synergy upgrades going forward? Thanks a lot.

Absolutely. Lot of stuff there. Let me -- so number one, as I -- the legacy Clariant performance for 2020. And I mean, look, recall that this is a business that went through the pandemic just like the rest of our, so when you look at 13% EBITDA growth on the surface of it, someone may or you have to put the year in context to really appreciate that. And I go back to the second quarter of the year when EBITDA was flat, but flat was awesome in Q2, right? So and that really was a testament to their presence in healthcare and food and beverage packaging is really two key end markets, which is again, I think, a growth driver for the all full year results. And that is, look, organic, with the exception of how you call organic and the meaning that, yeah, we did achieve $5 million of synergies this year, a portion of that does go to the legacy Clariant business and we’re projecting $35 million coming up in the next year. The next question was around healthcare, and specifically, applications around catheters and vials. We do have a connection into minimally invasive catheters for certain types of procedures. And we also do have a connection, a pretty significant one into vials and test kits. So when, Jamie, was presenting the bridge schedule today, she said, hey, look, there’s some things that we did last year that may not repeat, for example, N95 mask, you probably won’t see the same level of demand for those in ‘21 as you did in ‘20. However, some of that could be offset by what we’re seeing with testing kits and so on. So that’s how we’ve tried to actually present that healthcare dynamic this year. And then, lastly, on the synergy targets, I do think there’s more opportunity from our operational perspective. Some of these things are a little bit longer term. There’s one in particular that we actually really like in this kind of in development right now, but I think given the timeframe that that will take place. We’re just not sure if that can happen inside that three-year time window. So for now we’re just trying to really focus on what can we get done from a cost perspective inside three years? If this other idea is something we can pull forward, we will and we’ll update our targets accordingly.

Thanks a lot.

Absolutely.

Thank you, Jaydeep.

Thank you. And our next question comes from the line of Vincent Anderson with Stifel. Your line is open. Please go ahead.

Yeah. Thanks. Good morning, everyone. Bob, maybe a tough number to pin down, but when you think about your 6% constant currency growth, given your confidence, how much of that would you be able to attribute to maybe specific applications or business wins you have a really good line of sight on versus maybe your assumptions on the broader cycle?

Yeah. Again, I got to kind of split the year into two halves. I’d say, look, right now, I feel like we got a really good read on the first quarter and we’re off to a strong start, and I think these estimates are conservative in that regard. What’s challenging are really sort of project is, how does this play out in the second half, and in particular, this fourth quarter, which, as you know, was really strong for us in 2020 and how that manifests itself. So it’s always challenging for us to try to put granular assumptions out there on these specific applications. But right now, with what we’re seeing in the first half of the year, if you go on look at the bridge schedule, Jamie presented, we feel good about those categories and the applications that are inside of those. We got pretty good line of sight too.

Excellent. Thanks. And then maybe can we hit reset really quick on composites? You said we’re still holding around $200 million of sales, obviously, 2020 being tough, but maybe just revisiting kind of a rough breakdown between the different businesses that are in there. How many of those are still in the process of being commercialized and maybe a bit of a drag on margins today? And then just finally, what you’re excited to be bringing to the market now that we’re kind of moving back to a more normal demand environment?

Yeah. Look, there’s about, I’d say, $60 million of that to, let’s say, $80 million is really directly related to 5G and fiber optic infrastructure that come up really at all today, I think, is a good grower for us that we’ve put it in this composite bucket. And then, of course, we’ve got composites that are directly going into the outdoor space, which was probably another $40 million to $60 million with a balance being in industrial applications and some presence in oil and gas exploration. I’m not sure if that works out perfectly to being a third, a third, a third. But hopefully that helps gives you some better perspective on the breakdown. By end market, there isn’t one of those. That -- I mean they’re all really good and very profitable by end market, looking at it that way. It’s kind of by technology where you see some differences and if I look at some of the leading edge thermoplastic composite technology that’s placed where we still got a significant amount of investment, still a lot of customer acceptance to come to get some new products introduced, but a lot opportunity for the future. So there’s some mix in margin there by technology, but not really by end market.

That’s helpful. Thank you.

Absolutely.

Thank you. And this does conclude today’s question-and-answer session. And I would like to turn the conference back over to Bob Patterson for any further remarks.

All right. Well, thanks everyone for joining us on the call. We look forward to hopefully seeing many of you in, well, maybe not in person but on WebEx or otherwise and some upcoming conferences and along the way, and of course, updating you on our first quarter results when we have those in hand end of April, beginning of May. Take care. Bye for now.

Ladies and gentlemen, this does conclude today’s program. You may all disconnect. Everyone have a great day.